Skip to main content
Signal8

Roth David

SEC insider (Form 3/4/5 filer). CIK 0001599014. Chief Medical Officer at Syros Pharmaceuticals, Inc. (SYRS). 3 reported Form 4/5 transactions since Sep 2024; latest on Nov 18, 2024. Located in CAMBRIDGE, MA.

Companies Roth David has filed insider reports for

  • Syros Pharmaceuticals, Inc. (SYRS): Officer, Chief Medical Officer
Roth David profile photo

Roth David

CIK: 0001599014

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (33.3%)

Position reduction

Option Exercises (M)1 (33.3%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Syros Pharmaceuticals, Inc. logo
SYRS

Syros Pharmaceuticals, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Syros Pharmaceuticals, Inc. logo
    SYRS

    Syros Pharmaceuticals, Inc.

    Nov 18, 2024
    Sale
    Direct
    12.1K shares at avg. $0.20$2K
  • Syros Pharmaceuticals, Inc. logo
    SYRS

    Syros Pharmaceuticals, Inc.

    Oct 31, 2024
    Exercise
    Direct
    18.9K shares-
  • Syros Pharmaceuticals, Inc. logo
    SYRS

    Syros Pharmaceuticals, Inc.

    Oct 31, 2024
    Tax Payment
    Direct
    6.8K shares at avg. $2.09$14K

1-3 of 3